Assenagon Asset Management S.A. Pacira Bio Sciences, Inc. Transaction History

Assenagon Asset Management S.A.

$54.8 Billion
Q1 2025

A detailed history of Assenagon Asset Management S.A. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 673,289 shares of PCRX stock, worth $16.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

673,289

Previous 452,093 48.93%

Holding current value

$16.6 Million

Previous $8.52 Million 96.44%

% of portfolio

0.03%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$18.33 - $27.25 $4.05 Million - $6.03 Million	221,196 Added 48.93%	673,289 $16.7 Million
Q4 2024 Jan 14, 2025	SELL	$15.3 - $20.33 $1.55 Million - $2.05 Million	-101,021 Reduced 18.26%	452,093 $8.52 Million
Q3 2024 Oct 23, 2024	BUY	$11.7 - $28.46 $4.91 Million - $11.9 Million	419,656 Added 314.45%	553,114 $8.33 Million
Q2 2024 Jul 18, 2024	SELL	$25.5 - $31.51 $1.6 Million - $1.98 Million	-62,837 Reduced 32.01%	133,458 $3.82 Million
Q1 2024 Apr 24, 2024	SELL	$27.7 - $35.48 $1.39 Million - $1.79 Million	-50,326 Reduced 20.41%	196,295 $5.74 Million
Q4 2023 Jan 17, 2024	BUY	$26.32 - $34.31 $4.22 Million - $5.49 Million	160,149 Added 185.2%	246,621 $8.32 Million
Q3 2023 Nov 06, 2023	SELL	$30.68 - $40.09 $3.73 Million - $4.87 Million	-121,415 Reduced 58.4%	86,472 $2.65 Million
Q2 2023 Jul 25, 2023	BUY	$36.12 - $47.5 $2.02 Million - $2.66 Million	56,063 Added 36.93%	207,887 $8.33 Million
Q1 2023 Apr 18, 2023	BUY	$35.53 - $43.38 $5.39 Million - $6.59 Million	151,824 New	151,824 $6.2 Million
Q1 2022 Apr 25, 2022	SELL	$60.03 - $76.49 $8.43 Million - $10.7 Million	-140,468 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$47.97 - $62.21 $5.22 Million - $6.77 Million	108,873 Added 344.59%	140,468 $8.45 Million
Q3 2021 Oct 19, 2021	SELL	$54.64 - $61.3 $2.03 Million - $2.28 Million	-37,171 Reduced 54.05%	31,595 $1.77 Million
Q1 2021 Apr 26, 2021	SELL	$59.31 - $78.82 $296 - $394	-5 Reduced 0.01%	68,766 $4.82 Million
Q4 2020 Feb 01, 2021	BUY	$50.47 - $66.26 $3.47 Million - $4.56 Million	68,771 New	68,771 $4.12 Million
Q3 2020 Oct 07, 2020	SELL	$51.97 - $63.0 $3.8 Million - $4.61 Million	-73,202 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$30.8 - $52.47 $2.25 Million - $3.84 Million	73,202 New	73,202 $3.84 Million

Others Institutions Holding PCRX

# of Institutions

258

Shares Held

49.4M

Call Options Held

1.03M

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.13B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Pacira Bio Sciences, Inc. Transaction History